Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Myriad Genetics, Inc.    MYGN

MYRIAD GENETICS, INC.

(MYGN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/16/2019 08/19/2019 08/20/2019 08/21/2019 08/22/2019 Date
25.35(c) 25.08(c) 24.49(c) 25.09(c) 23.98 Last
2 055 752 1 667 724 1 064 248 620 343 414 500 Volume
+9.27% -1.07% -2.35% +2.45% -4.42% Change
More quotes
Financials (USD)
Sales 2020 875 M
EBIT 2020 164 M
Net income 2020 36,0 M
Finance 2020 130 M
Yield 2020 -
Sales 2021 916 M
EBIT 2021 182 M
Net income 2021 55,6 M
Finance 2021 263 M
Yield 2021 -
P/E ratio 2020 53,4x
P/E ratio 2021 33,9x
EV / Sales2020 1,97x
EV / Sales2021 1,74x
Capitalization 1 853 M
More Financials
Company
Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative... 
More about the company
Surperformance© ratings of Myriad Genetics, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on MYRIAD GENETICS, INC.
10:53aINVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claim..
BU
08:01aBRAGAR EAGEL & SQUIRE, P.C. IS INVES : MYGN) on Behalf of Stockholders and Encou..
PR
07:43aMYRIAD GENETICS : Applauds the U.S. Preventive Services Task Force Recommendatio..
PU
07:06aMyriad Applauds the U.S. Preventive Services Task Force Recommendation on BRC..
GL
08/21INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims A..
BU
08/21Investigation of Myriad Genetics Announced by Holzer & Holzer, LLC
BU
08/20Rosen Law Firm Announces Investigation of Securities Claims Against Myriad Ge..
BU
08/19MYRIAD GENETICS : Hagens Berman Investigating Myriad Genetics (MYGN) For Possibl..
PR
08/16INVESTOR ALERT : Kaplan Fox Investigates Myriad Genetics, Inc.
PR
08/13MYRIAD GENETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
More news
Analyst Recommendations on MYRIAD GENETICS, INC.
More recommendations
Sector news : Medical Diagnostic & Testing Equipment
08/21EXCLUSIVE : Philips, under investigation in U.S. and Brazil, fired whistleblower..
RE
08/15AGILENT TECHNOLOGIES : Up 8.3% After Earnings, Guidance
DJ
08/15Agilent Up Over 8%, on Pace for Largest Percent Increase Since November 2013 ..
DJ
08/14AGILENT TECHNOLOGIES : Posts Lower 3Q Profit, Raises Guidance
DJ
08/09GLOBAL MARKETS LIVE : Bayer, Huawei, Airbus, Occidental Petroleum…
More sector news : Medical Diagnostic & Testing Equipment
Chart MYRIAD GENETICS, INC.
Duration : Period :
Myriad Genetics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MYRIAD GENETICS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 32,50  $
Last Close Price 25,09  $
Spread / Highest target 87,3%
Spread / Average Target 29,5%
Spread / Lowest Target -16,3%
EPS Revisions
Managers
NameTitle
Mark C. Capone President, Chief Executive Officer & Director
John Tannahill Henderson Chairman
Gary A. King Executive Vice President-International Operations
R. Bryan Riggsbee CFO, Treasurer, Principal Accounting Officer & EVP
Robert Gardner Harrison Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
MYRIAD GENETICS, INC.-13.69%1 853
SARTORIUS74.48%13 029
VAREX IMAGING CORP15.12%1 045
CELLAVISION AB84.33%896
OXFORD IMMUNOTEC GLOBAL PLC9.15%374
ALPHATEC HOLDINGS INC161.57%361